nct01728454 study id: zpe-202 title: a phase 2, multi
TRANSCRIPT
![Page 1: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/1.jpg)
NCT01728454
Study ID: ZPE-202
Title: A Phase 2, Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 12 mg Proellex® (Telapristone Acetate) Administered
Vaginally in the Treatment of Premenopausal Women with Confirmed Symptomatic Uterine Fibroids
Statistical Analysis Plan Date: 30 August 2016
![Page 2: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/2.jpg)
![Page 3: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/3.jpg)
![Page 4: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/4.jpg)
![Page 5: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/5.jpg)
![Page 6: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/6.jpg)
![Page 7: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/7.jpg)
![Page 8: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/8.jpg)
![Page 9: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/9.jpg)
![Page 10: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/10.jpg)
![Page 11: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/11.jpg)
![Page 12: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/12.jpg)
![Page 13: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/13.jpg)
![Page 14: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/14.jpg)
![Page 15: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/15.jpg)
![Page 16: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/16.jpg)
![Page 17: NCT01728454 Study ID: ZPE-202 Title: A Phase 2, Multi](https://reader030.vdocuments.us/reader030/viewer/2022020623/61f0fefaeaf22c696f2d11f3/html5/thumbnails/17.jpg)